Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients.

about

Effects of hyperglycemia on the development of new-onset diabetes after liver transplantation.Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation.

P2860

Q43202249-35222746-FC9F-438D-B405-1A4C8B665ECC Q51602348-83142A9D-F00E-48EC-ADCF-DDC056362663

P2860

Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients.

Item

http://www.wikidata.org/entity/Q46942515

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Relationships of tacrolimus ph ...... t liver transplant recipients.

@en

Relationships of tacrolimus ph ...... t liver transplant recipients.

@nl

type

Item

label

Relationships of tacrolimus ph ...... t liver transplant recipients.

@en

Relationships of tacrolimus ph ...... t liver transplant recipients.

@nl

prefLabel

Relationships of tacrolimus ph ...... t liver transplant recipients.

@en

Relationships of tacrolimus ph ...... t liver transplant recipients.

@nl

P1476

Relationships of tacrolimus ph ...... t liver transplant recipients.

@en

P2093

Dansirikul C

http://www.w3.org/2001/XMLSchema#string

Lynch SV

http://www.w3.org/2001/XMLSchema#string

Taylor PJ

http://www.w3.org/2001/XMLSchema#string

Tett SE

http://www.w3.org/2001/XMLSchema#string

P2860

Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.

Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients.

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.

Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.

The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.

Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in japan.

Sampling times for monitoring tacrolimus in stable adult liver transplant recipients.

P304

17-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2710.2006.00697.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christine E. Staatz

Stephen B. Duffull

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16476116

http://www.w3.org/2001/XMLSchema#string

Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients.

about

P2860

P2860

Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698